Servier acquires Day One Biopharma

Servier agreed to acquire Day One Biopharma. Reported deal value: $2.5B. Status: Pending. Sector: medical. Target headquarters context: Brisbane, California, United States.

This page summarizes publicly available information about the transaction as of 2026-03-06. Figures and status may change as filings and press coverage update.

Day One Biopharmaceuticals to Be Acquired by Servier in $ 21 . 50 -Per- Share Tender Offer Less than 1 min read DAWN Day One Biopharmaceuticals entered into a definitive merger agreement with Servier , under which Servier will commence a tender offer to acquire all outstanding shares for $ 21 . 50 in cash per share, followed by a back-end merger